Stoke Therapeutics Inc’s recent filing unveils that its CHIEF MEDICAL OFFICER Ticho Barry unloaded Company’s shares for reported $0.15 million on Jun 03 ’24. In the deal valued at $15.22 per share,10,000 shares were sold. As a result of this transaction, Ticho Barry now holds 2,485 shares worth roughly $34466.95.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Nash Huw M. sold 50,000 shares, generating $769,500 in total proceeds. Upon selling the shares at $15.39, the COO & CBO now owns 0 shares.
Before that, Kaye Edward M. MD sold 42,350 shares. Stoke Therapeutics Inc shares valued at $653,529 were divested by the CEO at a price of $15.43 per share. As a result of the transaction, Kaye Edward M. MD now holds 27,000 shares, worth roughly $0.37 million.
TD Cowen upgraded its Stoke Therapeutics Inc [STOK] rating to an Outperform from a a Market perform in a research note published recently. TD Cowen also remained covering STOK and has decreased its forecast on July 25, 2023 with a “Market perform” recommendation from previously “an Outperform” rating. BofA Securities revised its rating on May 01, 2023. It rated STOK as “a Neutral” which previously was an “an Underperform”.
Price Performance Review of STOK
On Monday, Stoke Therapeutics Inc [NASDAQ:STOK] saw its stock jump 2.66% to $13.87. Over the last five days, the stock has lost -3.21%. Stoke Therapeutics Inc shares have risen nearly 163.69% since the year began. Nevertheless, the stocks have risen 32.10% over the past one year. While a 52-week high of $17.58 was reached on 06/13/24, a 52-week low of $3.35 was recorded on 02/13/24. SMA at 50 days reached $13.75, while 200 days put it at $7.78. A total of 0.96 million shares were traded, compared to the trading of 3.18 million shares in the previous session.
Levels Of Support And Resistance For STOK Stock
The 24-hour chart illustrates a support level at 13.51, which if violated will result in even more drops to 13.14. On the upside, there is a resistance level at 14.12. A further resistance level may holdings at 14.37. The Relative Strength Index (RSI) on the 14-day chart is 46.51, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.32, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 76.97%. Stochastics%K at 16.67% indicates the stock is a buying.
